GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MAKO SURGICAL CORP (MAKO) [hlAlert]

Rating:
Market Perform
MAKO
up 140.01 %

MAKO SURGICAL CORP (MAKO) downgraded to Market Perform by Wells Fargo

Posted on: Thursday,  Sep 26, 2013  8:25 AM ET by Wells Fargo

Wells Fargo rated Market Perform MAKO SURGICAL CORP (NASDAQ: MAKO) on 09/26/2013. Previously Wells Fargo rated Outperform MAKO SURGICAL CORP (NASDAQ: MAKO)
on 05/28/2013., when the stock price was $12.27. Since then, MAKO SURGICAL CORP has gained 140.02% as of 09/26/2013's recent price of $29.45.
If you would have followed the previous Wells Fargo's recommendation on MAKO, you would have gained 140.01% of your investment in 121 days.

MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, early to mid-stage osteoarthritic knee disease. Its robotic arm systems, branded as its first generation Tactile Guidance System (TGS), and its second generation RIO Robotic Arm Interactive Orthopedic system (RIO), utilize tactile guided robotic arm technology and patient specific visualization to prepare the knee joint for the insertion and alignment of its resurfacing implants through a small incision in a minimally invasive, bone preserving and tissue sparing procedure. MAKO has an intellectual property portfolio of more than 250 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, robotics, haptics and implants.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/26/2013 8:25 AM Hold
None
29.45
as of 12/13/2013
1 Week   
1 Month   
3 Months up  81.56 %
1 YTD up  140.01 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/28/2013 8:25 AM Buy
None
12.27
9/5/2012 8:25 AM Hold
None
15.90
1/5/2010 10:25 AM Sell
None
11.20

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy